CAS 1401436-95-0

4-[2-(Difluoromethyl)-1H-benzimidazol-1-yl]-N-[1,1-dimethyl-2-[2-(1-methyl-4-piperidinyl)phenyl]ethyl]-6-(4-morpholinyl)-1,3,5-triazin-2-amine

CAS : 1401436-95-0

Formule : C₃₁H₃₈F₂N₈O

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 576.6832

Ref: IN-DA001C2J

Zandelisib

CAS : 1401436-95-0

Zandelisib

Degré de pureté : ≥98%

Masse moléculaire : 576.68g/mol

Ref: 54-BUP08765

Zandelisib-13c-d3

CAS : 1401436-95-0

Formule : C₃₀₁₃CH₃₅D₃F₂N₈O

Masse moléculaire : 580.71

Ref: 4Z-Z-040002

Zandelisib

CAS : 1401436-95-0

Formule : C₃₁H₃₈F₂N₈O

Masse moléculaire : 576.70

Ref: 4Z-Z-040001

Zandelisib

CAS : 1401436-95-0

Zandelisib is an inhibitor of phosphatidylinositol 3-kinase (PI3K)(p110δ, IC50 of 3.5 nM), and with antineoplastic activity.

Formule : C₃₁H₃₈F₂N₈O

Degré de pureté : 99.88%

Couleur et forme : Solid

Masse moléculaire : 576.68

Ref: TM-T13386

Zandelisib

CAS : 1401436-95-0

Zandelisib is a cell-permeable peptide ligand that binds to the extracellular domain of human EGFR. It has been shown to inhibit receptor activation and signaling, as well as receptor-mediated endocytosis. Zandelisib also inhibits protein interactions with receptors, including those of the epidermal growth factor family.

Formule : C₃₁H₃₈F₂N₈O

Degré de pureté : Min. 95%

Masse moléculaire : 576.7 g/mol

Ref: 3D-BGC43695